And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the ...

Initiative will eliminate up to 25% of all reauthorizations, or 10% of overall prior authorizations, PBM says.

Many trials exclude certain groups, and do so deliberately—children, for example, or people with physical or learning ...

We have produced resources about lecanemab for you and your patients. Find out more below. Donanemab (brand name Kisunla®) is a new medication used to treat the very early stages of Alzheimer's ...

Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?

John Peters said the clinical trial he participated in at the Kawartha Centre gave him parts of his life back.

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage ...

Not the Same. In amyloid-negative people (left) few tangles accumulate over a decade. In amyloid-positives (right), tangles grow faster in women (red) than men (blue). [Courtesy of Gillian Coughlan, ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...